Ozempic is pretty new for those wanting it to lose weight, and celebrities like Jeremy Clarkson and Amy Schumer have shared ...

Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...

The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...

BORDERLINE alcoholic’ Shane Harding claims King Kong weight loss jab Mounjaro helped her shed six stone by curbing her ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Health and wellness influencer Janelle Rohner has received backlash after revealing in a YouTube video posted on April 23 ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...

In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...